Sotera Health’s (SHC) Underweight Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. reaffirmed their underweight rating on shares of Sotera Health (NASDAQ:SHC) in a research report report published on Wednesday morning, Marketbeat.com reports. The brokerage currently has a $17.00 price target on the stock.

SHC has been the topic of a number of other reports. Barclays boosted their target price on shares of Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. UBS Group set a $19.00 target price on shares of Sotera Health in a research note on Wednesday, June 24th. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price target on shares of Sotera Health in a report on Tuesday, September 8th. Citigroup lifted their price target on shares of Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Finally, Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 29th. Nine research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and an average target price of $21.38.

Sotera Health Price Performance

SHC stock opened at $17.89 on Wednesday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. Sotera Health has a 1 year low of $13.09 and a 1 year high of $19.85. The firm has a market cap of $5.11 billion, a P/E ratio of 21.26 and a beta of 1.85. The stock has a 50-day simple moving average of $18.67 and a 200-day simple moving average of $17.16.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.24 by $0.02. The business had revenue of $321.38 million for the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%. The company’s revenue was up 9.2% on a year-over-year basis. During the same period last year, the business posted $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, equities analysts predict that Sotera Health will post 0.87 earnings per share for the current fiscal year.

Insider Activity at Sotera Health

In other news, insider Michael P. Rutz sold 150,000 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the transaction, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the sale, the chairman directly owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. The trade was a 17.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. Company insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Meeder Asset Management Inc. bought a new stake in shares of Sotera Health in the 2nd quarter worth about $37,000. Root Financial Partners LLC lifted its position in shares of Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after purchasing an additional 1,455 shares during the last quarter. Nykredit A S bought a new position in shares of Sotera Health during the second quarter worth about $50,000. IFP Advisors Inc lifted its position in shares of Sotera Health by 150.8% during the second quarter. IFP Advisors Inc now owns 3,509 shares of the company’s stock worth $62,000 after purchasing an additional 2,110 shares during the last quarter. Finally, Strs Ohio lifted its position in shares of Sotera Health by 20.1% during the first quarter. Strs Ohio now owns 5,881 shares of the company’s stock worth $84,000 after purchasing an additional 986 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Company Profile

Sotera Health Company (NASDAQ:SHC) is a global provider of healthcare services focused on sterilization, laboratory testing and infection prevention. The company serves medical device manufacturers, pharmaceutical companies, biotechnology businesses, hospitals and other healthcare organizations.

Sotera Health operates through three primary businesses. Sterigenics provides outsourced sterilization and medical device services using technologies such as ethylene oxide, gamma irradiation and electron beam processing.